BMS-823778

DRUG5 trials

Sponsors

Bristol-Myers Squibb

Conditions

Atherosclerotic Cardiovascular DiseaseDiabetes Mellitus, Type 2DyslipidemiaHypertensionType 2 Diabetes Mellitus

Phase 1

Japanese Phase 1 Multiple Ascending Dose Study

CompletedNCT01515202

Bristol-Myers SquibbType 2 Diabetes Mellitus

Start: 2012-03-31End: 2012-09-30Updated: 2012-12-05

Phase 2

Safety Study of BMS-823778 in Subjects With Type 2 Diabetes

CompletedNCT01111955

Bristol-Myers SquibbDiabetes Mellitus, Type 2

Start: 2010-07-31End: 2011-01-31Updated: 2015-10-12

Safety Study of BMS-823778 in Subjects With Hypercholesterolemia

CompletedNCT01112423

Bristol-Myers SquibbDyslipidemia

Start: 2010-06-30End: 2010-12-31Updated: 2015-10-12

Safety and Efficacy Study of BMS-823778 to Treat Uncontrolled High Blood Pressure in Overweight and Obese Patients

TerminatedNCT01602367

Bristol-Myers SquibbHypertension

Start: 2012-07-31End: 2012-11-30Updated: 2015-10-12

Proof of Concept Study of BMS-823778 to Assess the Effects on Atherosclerosis

WithdrawnNCT01666704

Bristol-Myers SquibbAtherosclerotic Cardiovascular Disease

Start: 2014-04-30End: 2016-05-31Updated: 2013-06-21